CIPLA.NS(CIPLA.NS)
CIPLA.NS
No analyst ratings available
No analyst price targets available for CIPLA.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|
| Revenue Avg | $309.39B | $347.05B | $379.39B | $431.70B |
| Low | $296.10B | $326.97B | $355.45B | $408.57B |
| High | $328.70B | $363.43B | $397.70B | $454.58B |
| EBITDA Avg | $69.54B | $84.31B | $93.72B | $135.10B |
| Low | $60.38B | $74.51B | $84.93B | $126.82B |
| High | $77.16B | $92.96B | $107.37B | $143.30B |
| EBIT Avg | $56.92B | $70.92B | $79.41B | $119.57B |
| Low | $47.76B | $61.12B | $70.62B | $111.28B |
| High | $64.54B | $79.57B | $93.07B | $127.76B |
| Net Income Avg | $41.19B | $51.44B | $57.65B | $87.04B |
| Low | $34.48B | $44.26B | $51.22B | $80.98B |
| High | $46.76B | $57.77B | $67.64B | $93.04B |
| EPS Avg | $51.11 | $63.90 | $71.75 | $107.70 |
| Low | $42.67 | $54.77 | $63.37 | $100.20 |
| High | $57.86 | $71.48 | $83.70 | $115.12 |
| Analysts (Rev / EPS) | 36 / 32 | 36 / 32 | 17 / 14 | 8 / 7 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 |
|---|---|---|---|---|
| Revenue Avg | $75.33B | $80.18B | $78.27B | $84.40B |
| Low | $74.00B | $79.56B | $77.30B | $83.35B |
| High | $77.73B | $80.84B | $79.82B | $86.06B |
| EBITDA Avg | $15.56B | $18.20B | $16.61B | $18.49B |
| Low | $14.65B | $17.03B | $16.39B | $18.25B |
| High | $16.47B | $19.38B | $16.95B | $18.88B |
| EBIT Avg | $12.49B | $15.10B | $13.47B | $15.31B |
| Low | $11.58B | $13.92B | $13.26B | $15.07B |
| High | $13.40B | $16.27B | $13.82B | $15.70B |
| Net Income Avg | $9.03B | $10.94B | $9.75B | $11.10B |
| Low | $8.37B | $10.08B | $9.60B | $10.92B |
| High | $9.70B | $11.80B | $10.00B | $11.38B |
| EPS Avg | $11.18 | $13.54 | $12.06 | $13.73 |
| Low | $10.35 | $12.47 | $11.87 | $13.51 |
| High | $12.00 | $14.60 | $12.37 | $14.08 |
| Analysts (Rev / EPS) | 4 / 2 | 4 / 2 | 2 / 1 | 2 / 1 |